HALO logo
halo search icon
Mineralys Therapeutics, Inc.

US$28.43

Price Change Indicator
2.40 (9.22%)
Mineralys Therapeutics, Inc.
MLYS · NAS

Mineralys Therapeutics, Inc.

Start Trading MLYS for Free

US$28.43

Price Arrow2.40 (9.22%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusFakey Shakey - Long (Realtime)HALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Mineralys Therapeutics, Inc. Overview

MLYS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MLYS

icon

Website

Mineralys Therapeutics, Inc.

icon

Telephone

1.888.378.6240

icon

Address

Suite F200, 150 North Radnor Chester Road, Radnor, PA 19087

Description

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

MLYS Price Chart

Key Stats

Market Cap

US$2.15B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 12.59 - 47.65

Trade Value (12mth)

US$9,992,694.00

1 week

-4.93%

1 month

-9.56%

YTD

-27.11%

1 year

56.24%

All time high

47.65

Key Fundamentals

EPS 3 yr Growth

213.40%

EBITDA Margin

0.00%

Operating Cashflow

-$142m

Free Cash Flow Return

-34.00%

ROIC

-36.90%

Interest Coverage

0.00

Quick Ratio

43.80

Other Data

Shares Outstanding (Fully Diluted)

83m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MLYS Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
07 May 26
10 March 26

MLYS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.99-3.66-2.29locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.99-3.66-2.29locklocklock
Growth
 %locklocklocklock-172.4-84.437.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Mineralys Therapeutics, Inc. (MLYS:NAS)?
Halo FAQ
The current share price of Mineralys Therapeutics, Inc. (MLYS:NAS) is USD$28.43.
What is the 52-week high share price for Mineralys Therapeutics, Inc. (MLYS:NAS)?
Halo FAQ
The 52-week high share price for Mineralys Therapeutics, Inc. (MLYS:NAS) is USD$47.65.
What is the 52-week low share price for Mineralys Therapeutics, Inc. (MLYS:NAS)?
Halo FAQ
The 52-week low share price for Mineralys Therapeutics, Inc. (MLYS:NAS) is USD$12.59.
What is the dividend yield for Mineralys Therapeutics, Inc. (MLYS:NAS)?
Halo FAQ
Mineralys Therapeutics, Inc. (MLYS:NAS) does not pay a dividend.
What was Mineralys Therapeutics, Inc. (MLYS:NAS) last dividend payment?
Halo FAQ
Mineralys Therapeutics, Inc. (MLYS:NAS) does not pay a dividend.
What is the franking level for Mineralys Therapeutics, Inc. (MLYS:NAS)?
Halo FAQ
Mineralys Therapeutics, Inc. (MLYS:NAS) has a franking level of 0.00%.
In which sector is Mineralys Therapeutics, Inc. (MLYS:NAS) classified?
Halo FAQ
Mineralys Therapeutics, Inc. (MLYS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial